<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
  <title>Jiagen Biotechnologies</title>
  <link rel="icon" type="image/x-icon" href="../../assets/favicon.ico">
  <script src="https://cdn.jsdelivr.net/npm/alpinejs@3.x.x/dist/cdn.min.js" defer></script>
  <link href="../../dist/output.css" rel="stylesheet" />

  
</head>
<body class="bg-gray-100 text-gray-800">
  <!-- Announcement Bar -->
  <div class="bg-brandblue text-white text-sm py-1 px-4">
    <div class="max-w-7xl mx-auto flex justify-between items-center">
      <div class="hidden md:flex"><span>Empowering Life Science Research</span></div>
      <div class="flex space-x-6 md:hidden">
        <!-- Mobile: show just one link -->
        <span>Phone: <span class="font-semibold">514-779-9623</span></span>
        <span>Orders: <span class="font-semibold">sales@jiagen.com</span></span>
      </div>
        <!-- Desktop: show full info -->
        <div class="hidden md:flex space-x-6">
          <span>Phone: <span class="font-semibold">514-779-9623</span></span>
          <span>Contact: <span class="font-semibold">info@jiagen</span></span>
          <span>Orders: <span class="font-semibold">sales@jiagen.com</span></span>
        </div>
    </div>
  </div>
 <!-- Header -->
<header class="sticky top-0 z-50 bg-white shadow">
    <div class="max-w-7xl mx-auto px-4 py-1 flex justify-between items-center relative">
      <a href="../../index.html">
        <img src="../../assets/logo.svg" alt="Logo" class="h-20 w-auto" />
      </a>
      <!-- Mobile Menu Toggle Button -->
    <div class="md:hidden" x-data="{ open: false }">
        <button @click="open = !open" class="text-slate-800 focus:outline-none">
        <svg class="w-6 h-6" fill="none" stroke="currentColor" viewBox="0 0 24 24">
            <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2"
            d="M4 6h16M4 12h16M4 18h16"/>
        </svg>
        </button>
    
        <!-- Mobile Dropdown Menu -->
        <div x-show="open" @click.away="open = false" class="absolute left-0 top-full w-full bg-white shadow-md z-50 border-t mt-2">
        <ul class="p-4 space-y-2 font-medium text-sm">
            
            <!-- PRODUCTS dropdown -->
            <li x-data="{ openSub: false }">
            <button @click="openSub = !openSub" class="w-full text-left flex justify-between items-center py-2 text-slate-800 hover:text-slate-900">
                Products
                <svg class="w-4 h-4 transform transition-transform" :class="{ 'rotate-180': openSub }" fill="none" stroke="currentColor" viewBox="0 0 24 24">
                <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M6 9l6 6 6-6"/>
                </svg>
            </button>
            <ul x-show="openSub" class="pl-4 mt-2 space-y-1 text-sm" x-cloak>
              <li><a href="../proteins/proteins.html" class="block py-1 hover:text-blue-700">Peptides / Proteins</a></li>
              <li><a href="../enzymes/enzymes.html" class="block py-1 hover:text-blue-700">Enzymes</a></li>
              <li><a href="../coenzymes/coenzymes.html" class="block py-1 hover:text-blue-700">Coenzymes</a></li>
              <li><a href="../carbohydrates/carbohydrates.html" class="block py-1 hover:text-blue-700">Carbohydrates</a></li>
              <li><a href="../chemicals/chemicals.html" class="block py-1 hover:text-blue-700">Chemicals</a></li>
            </ul>
            </li>
    
            <!-- Other links -->
            <li><a href="../../order.html" class="block py-2 text-slate-800 hover:text-slate-900">Order</a></li>
        </ul>
        </div>
    </div>
    
  
      <!-- Desktop Nav -->
      <nav class="hidden md:flex space-x-6 items-center w-full">
        <ul class="flex flex-nowrap items-center font-medium text-base">
          <li class="p-4 lg:px-8 relative flex items-center space-x-1"
              x-data="{ open: false }"
              @mouseenter="open = true"
              @mouseleave="open = false">
            <a class="text-slate-800 hover:text-slate-900" href="#0" :aria-expanded="open">Products</a>
            <button class="shrink-0 p-1" :aria-expanded="open">
              <span class="sr-only">Show submenu for "products"</span>
              <svg class="w-3 h-3 fill-slate-500" xmlns="http://www.w3.org/2000/svg" width="12" height="12">
                <path d="M10 2.586 11.414 4 6 9.414.586 4 2 2.586l4 4z" />
              </svg>
            </button>
            <ul class="origin-top-right absolute top-full left-1/2 -translate-x-1/2 min-w-[240px] 
                       bg-white border border-slate-200 p-2 rounded-lg shadow-xl [&[x-cloak]]:hidden"
                x-show="open"
                x-transition:enter="transition ease-out duration-200 transform"
                x-transition:enter-start="opacity-0 -translate-y-2"
                x-transition:enter-end="opacity-100 translate-y-0"
                x-transition:leave="transition ease-out duration-200"
                x-transition:leave-start="opacity-100"
                x-transition:leave-end="opacity-0"
                x-cloak>
                <li><a class="text-slate-800 hover:bg-slate-50 flex items-center p-2" href="../proteins/proteins.html"><span>Peptides / Proteins</span></a></li>
                <li><a class="text-slate-800 hover:bg-slate-50 flex items-center p-2" href="../enzymes/enzymes.html"><span>Enzymes</span></a></li>
                <li><a class="text-slate-800 hover:bg-slate-50 flex items-center p-2" href="../coenzymes/coenzymes.html"><span>Coenzymes</span></a></li>
                <li><a class="text-slate-800 hover:bg-slate-50 flex items-center p-2" href="../carbohydrates/carbohydrates.html"><span>Carbohydrates</span></a></li>
                <li><a class="text-slate-800 hover:bg-slate-50 flex items-center p-2" href="../chemicals/chemicals.html"><span>Chemicals</span></a></li>

              </ul>
          </li>
  
          <li class="p-4 lg:px-8"><a class="text-slate-800 hover:text-slate-900" href="../../order.html">Order</a></li>
        </ul>
        <div class="flex items-center space-x-1">
          <!-- Search -->
          <div class="w-full max-w-xs min-w-[200px]">
              <div class="relative flex items-center">
              <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" fill="currentColor" class="absolute w-5 h-5 top-2.5 left-2.5 text-slate-600">
                  <path fill-rule="evenodd" d="M10.5 3.75a6.75 6.75 0 1 0 0 13.5 6.75 6.75 0 0 0 0-13.5ZM2.25 10.5a8.25 8.25 0 1 1 14.59 5.28l4.69 4.69a.75.75 0 1 1-1.06 1.06l-4.69-4.69A8.25 8.25 0 0 1 2.25 10.5Z" clip-rule="evenodd" />
              </svg>
          
              <input
              class="w-full bg-transparent placeholder:text-slate-400 text-slate-700 text-sm border border-slate-200 rounded-md pl-10 pr-3 py-2 transition duration-300 ease focus:outline-none focus:border-slate-400 hover:border-slate-300 shadow-sm focus:shadow"
              placeholder="Search Product" 
              />
      
              </div>
          </div>
          <ul class="flex flex-nowrap items-center font-medium text-sm">
              <li class="p-4 lg:px-8 relative flex items-center space-x-1"
                  x-data="{ open: false }"
                  @mouseenter="open = true"
                  @mouseleave="open = false">
                <a class="text-slate-800 hover:text-slate-900" href="#0" :aria-expanded="open">EN</a>
                <button class="shrink-0 p-1" :aria-expanded="open">
                  <span class="sr-only">Show submenu for languages</span>
                  <svg class="w-3 h-3 fill-slate-500" xmlns="http://www.w3.org/2000/svg" width="12" height="12">
                    <path d="M10 2.586 11.414 4 6 9.414.586 4 2 2.586l4 4z" />
                  </svg>
                </button>
                <ul class="origin-top-right absolute top-full left-1/2 -translate-x-1/2 min-w-[120px] 
                           bg-white border border-slate-200 p-2 rounded-lg shadow-xl [&[x-cloak]]:hidden"
                    x-show="open"
                    x-transition:enter="transition ease-out duration-200 transform"
                    x-transition:enter-start="opacity-0 -translate-y-2"
                    x-transition:enter-end="opacity-100 translate-y-0"
                    x-transition:leave="transition ease-out duration-200"
                    x-transition:leave-start="opacity-100"
                    x-transition:leave-end="opacity-0"
                    x-cloak>
                    <li><a class="text-slate-800 hover:bg-slate-50 flex items-center p-2" href="#"><span>English</span></a></li>
                    <li><a class="text-slate-800 hover:bg-slate-50 flex items-center p-2" href="./french/order_fr.html"><span>Fran√ßais</span></a></li>
                </ul>
              </li>
            </ul>
        </div>
      </nav>

    
  </header>
  <!-- Main Content -->
  <main class="max-w-6xl mx-auto px-6 py-12 text-slate-800 font-sans leading-relaxed">
    <div class="mb-8">
        <a href="enzymes.html" class="inline-flex items-center text-productblue hover:text-brandblue font-medium">
          <svg class="w-5 h-5 mr-2" fill="none" stroke="currentColor" stroke-width="2" viewBox="0 0 24 24"
            xmlns="http://www.w3.org/2000/svg">
            <path stroke-linecap="round" stroke-linejoin="round" d="M15 19l-7-7 7-7"></path>
          </svg>
          Enzymes
        </a>
      </div>
    <section>
      <h2 class="text-3xl font-bold text-brandblue border-b border-gray-300 pb-2 mb-4">Aprotinin  </h2>
      <p class="text-base text-gray-600 mb-2">
        <strong>CAS No.:</strong> 9087-70-1  &nbsp;|&nbsp;
        <strong>EINECS No.:</strong> 232-994-9 
      </p>
      <p class="mb-4"><strong>Synonyms:</strong> Basic trypsin inhibitor, bovine pancreatic trypsin inhibitor (BPTI), kallikrein inactivator, kunitz-type trypsin inhibitor, MGC148815, pancreatic trypsin inhibitor, protease inhibitor from bovine lung, PTI, serine protease inhibitor aprotinin, TKI, Trasylol¬Æ (brand name), trypsin-kallikrein inhibitor</p>
    </section>
  
    <section class="mt-8">
      <h3 class="text-2xl font-semibold text-brandblue mb-2">Product Summary</h3>
      <p>
        Aprotinin is a well-characterized, potent serine protease inhibitor derived from bovine lung. With its small size, tight structure, and high stability, it effectively inhibits several key proteases involved in proteolysis, coagulation, and inflammation. It is widely used in biochemistry and biomedical research to protect proteins from degradation and to study protease function and regulation. 
        <p class="pl-5 mt-2">Formula: C<sub>284</sub>H<sub>432</sub>N<sub>84</sub>O<sub>79</sub>S<sub>7</sub></span></p>
        <p class="pl-5">Molecular weight: ~6512 Da</p>
      </p>
    </section>
  
    <section class="mt-8">
      <h3 class="text-2xl font-semibold text-brandblue mb-2">Biochemical Function</h3>
      <p class="mb-2">Aprotinin is a broad-spectrum serine protease inhibitor that inhibits enzymes such as: </p>
      <ul class="list-disc list-outside space-y-2 text-base text-slate-700 pl-5">
        <li>Trypsin</li>
        <li>Chymotrypsin</li>
        <li>Plasmin</li>
        <li>Kallikrein</li>
        <li>Elastase (weakly)</li>
      </ul>
    </section>
  
    <section class="mt-8">
      <h3 class="text-2xl font-semibold text-brandblue mb-2">Mechanism of Action</h3>
      <ol class="list-decimal list-inside space-y-2 text-base text-slate-700">
        <li><strong>Reversible binding to active sites</strong>
            <p class="mt-2 pl-5">The inhibitory activity of aprotinin is largely due to its ability to mimic the natural substrate of 	the enzyme: Aprotinin presents a specific peptide loop (around its Lys15‚ÄìAla16 sequence) that 	mimics the enzyme's substrate. This loop fits precisely into the S1 specificity pocket of serine 	proteases, which is typically the primary binding site for the positively charged residue (e.g., 	lysine or arginine) of the substrate. This substrate-like conformation allows aprotinin to be 	recognized and bound by the enzyme as if it were a real substrate. 	Aprotinin binds to the active site of the target serine protease in a reversible manner, meaning 	the interaction is non-covalent and can be dissociated under the right conditions (e.g., dilution, 	change in pH or ionic strength)</p>
        </li>
        <li><strong>Formation of a tight, non-covalent enzyme-inhibitor complex</strong>
            <p class="mt-2 pl-5">Once docked into the active site, aprotinin forms a high-affinity, non-covalent complex with the 	enzyme: The inhibitor interacts with the catalytic triad (usually Ser-His-Asp) in the active site 	of the protease. However, because aprotinin is structurally stabilized by three internal disulfide 	bridges, it resists proteolytic cleavage, effectively "freezing" the enzyme in an inactive complex.
                The resulting complex is exceptionally stable (with dissociation constants in the sub-nanomolar 	range), thus effectively blocking the enzyme‚Äôs activity even at low concentrations.
            </p>
        </li>
        <li><strong>Inhibition of proteolytic activity</strong>
            <p class="mt-2 pl-5">By occupying the active site, aprotinin prevents access of natural substrates to the catalytic 	triad. Halts hydrolysis of peptide bonds by the enzyme. Suppresses downstream proteolytic 	cascades, such as fibrinolysis or kallikrein-mediated inflammatory responses.</p>
        </li>
        </ol>
    </section>
  
    <section class="mt-8">
      <h3 class="text-2xl font-semibold text-brandblue mb-2">Applications in Scientific Research</h3>
      <ol class="list-decimal list-inside space-y-2 text-base text-slate-700">
        <li><strong>Biochemical and molecular research </strong>
            <p class="mt-2 pl-5">Aprotinin is widely used in biochemical laboratories for its ability to inhibit unwanted proteolysis during experimental procedures. In many sample preparation protocols, endogenous proteases can be released and activated, leading to the degradation of target proteins. Aprotinin helps to preserve protein integrity in the following contexts: </p>
             <ul class="list-disc list-outside space-y-2 text-base text-slate-700 pl-10 mt-2">
                <li>Cell lysis: When cells are disrupted (mechanically or chemically), intracellular proteases are released. Aprotinin prevents these enzymes from degrading cytosolic or membrane-bound proteins.</li>
                <li>Protein purification: During affinity chromatography or other purification steps, proteins are exposed to environments where proteases may be active. Aprotinin maintains target protein stability and bioactivity.</li>
                <li>Tissue homogenization: Homogenization of tissue (e.g., brain, liver, muscle) can lead to the release of proteolytic enzymes. Adding aprotinin ensures the integrity of delicate signaling proteins, enzymes, or receptors.</li>
                <li>Protease Inhibition Cocktails: Aprotinin is a key component in commercial and custom-made protease inhibitor cocktails used in protein extraction buffers, often in combination with leupeptin, pepstatin A, and EDTA, to provide broad-spectrum protection against serine and other classes of proteases.</li>
            </ul>
        </li>
        <li><strong>Cell biology</strong>
            <p class="mt-2 pl-5">Aprotinin is used in cell culture and tissue engineering experiments where proteolytic regulation 	of the extracellular environment is critical:</p>
            <ul class="list-disc list-outside space-y-2 text-base text-slate-700 pl-10 mt-2">
               <li>Extracellular matrix (ECM) remodeling: Aprotinin is employed to modulate proteolytic 	activity in studies involving collagen, fibronectin, or matrix metalloproteinase (MMP) activity.</li>
               <li>Inflammation studies: By inhibiting kallikrein, aprotinin helps investigate the regulation of inflammatory mediators such as bradykinin and prostaglandins.</li>
               <li>Angiogenesis research: Aprotinin modulates protease-driven processes that influence endothelial cell migration and neovascularization, making it useful in angiogenesis assays and cancer metastasis studies.</li>
           </ul>
       </li>
       <li><strong>Hematology and thrombosis research</strong>
        <p class="mt-2 pl-5">Aprotinin is instrumental in coagulation and fibrinolysis research due to its ability to block 	serine proteases involved in blood clotting:</p>
        <ul class="list-disc list-outside space-y-2 text-base text-slate-700 pl-10 mt-2">
           <li>Fibrinolysis inhibition: Aprotinin inhibits plasmin, the main enzyme responsible for breaking down fibrin clots, and is used to study the regulation of clot stability and breakdown.</li>
           <li>Coagulation cascade studies: By inhibiting kallikrein, aprotinin indirectly affects the intrinsic coagulation pathway and contact system, helping researchers dissect the roles of individual proteases.</li>
           <li>Kallikrein-Kinin System Research: Aprotinin serves as a tool to explore the production of bradykinin, a potent vasodilator, by blocking the cleavage of kininogen by kallikrein.</li>
        </ul>
    </li>
    <li><strong>Enzyme kinetics and mechanistic studies</strong>
        <ul class="list-disc list-outside space-y-2 text-base text-slate-700 pl-10 mt-2">
            <li>Aprotinin is a model Kunitz-type protease inhibitor, often used in kinetic assays to determine inhibition constants (Ki) of serine proteases.</li>
            <li>It helps establish enzyme specificity, catalytic rates, and inhibitor binding modes by serving as a well-characterized competitive inhibitor.</li>
            <li>Crystallography and NMR studies involving aprotinin‚Äìenzyme complexes are fundamental in understanding enzyme-inhibitor interactions and are cited in numerous structural biology publications.</li>
        </ul>
    </li>
    <li><strong>Tissue and organ preservation</strong>
        <ul class="list-disc list-outside space-y-2 text-base text-slate-700 pl-10 mt-2">
            <li>Aprotinin has been investigated for its role in organ transplantation, particularly in kidney, liver, and pancreas preservation..</li>
            <li>During cold ischemia, proteases released from damaged cells can degrade structural and functional proteins. Aprotinin inclusion in preservation solutions helps reduce enzymatic degradation and improves post-transplant outcomes.</li>
        </ul>
    </li>
      </ol>
     
    </section>
  
    <section class="mt-8">
      <h3 class="text-2xl font-semibold text-brandblue mb-2">Packaging & Storage</h3>
      <ul class="list-disc list-inside space-y-1 text-base text-slate-700">
        <li>Sources: purified from bovine lungs </li>
        <li>Available as white to off-white hygroscopic powder</li>
        <li>Store in an airtight tamper-proof container, protected from light, at a temperature of 2&deg;C to 8&deg;C </li>
      </ul>
    </section>
  
    <section class="mt-10">
        <h3 class="text-2xl font-semibold text-brandblue mb-4">References</h3>
      
        <ol class="list-decimal list-inside space-y-2 text-sm text-slate-700">
          <li>Ascenzi P, et al. 2003: <a href="https://pubmed.ncbi.nlm.nih.gov/12769721/" target="_blank" class="text-blue-600 underline hover:text-blue-800">The bovine basic pancreatic trypsin inhibitor (Kunitz inhibitor): a milestone protein</a>, Curr Protein Pept Sci. 4(3): 231-51.</li>
          <li>Fritz H, Wunderer G. 1983: <a href="https://pubmed.ncbi.nlm.nih.gov/6191764/" target="_blank" class="text-blue-600 underline hover:text-blue-800">Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs</a>, Arzneimittelforschung 33(4): 479-94.</li>
          <li>Wegner J. 2003: <a href="https://pubmed.ncbi.nlm.nih.gov/14979425/" target="_blank" class="text-blue-600 underline hover:text-blue-800">Biochemistry of serine protease inhibitors and their mechanisms of action: a review</a>, J Extra Corpor Technol. 35(4): 326-38.</li>
          <li>Creighton TE. 1992: <a href="https://pubmed.ncbi.nlm.nih.gov/1373519/" target="_blank" class="text-blue-600 underline hover:text-blue-800">The disulfide folding pathway of BPTI</a>, Science 256(5053): 111-4.</li>
          <li>Weissman JS, Kim PS. 1991: <a href="https://pubmed.ncbi.nlm.nih.gov/1716783/" target="_blank" class="text-blue-600 underline hover:text-blue-800">Reexamination of the folding of BPTI: predominance of native intermediates</a>, Science 253(5026): 1386-93.</li>
          <li>States DJ, et al. 1980: <a href="https://pubmed.ncbi.nlm.nih.gov/7402343/" target="_blank" class="text-blue-600 underline hover:text-blue-800">A conformational isomer of bovine pancreatic trypsin inhibitor protein produced by refolding</a>, Nature 286(5773): 630-2.</li>
          <li>Zakharova E, et al. 2008: <a href="https://pubmed.ncbi.nlm.nih.gov/18692070/" target="_blank" class="text-blue-600 underline hover:text-blue-800">Functional and structural roles of the Cys14-Cys38 disulfide of bovine pancreatic trypsin inhibitor</a>, J Mol Biol. 382(4): 998-1013.</li>
          <li>Schwarz H, et al. 1987: <a href="https://pubmed.ncbi.nlm.nih.gov/2443162/" target="_blank" class="text-blue-600 underline hover:text-blue-800">Stability studies on derivatives of the bovine pancreatic trypsin inhibitor</a>, Biochemistry 26(12): 3544-51.</li>
          <li>Botos I, et al. 2001: <a href="https://pubmed.ncbi.nlm.nih.gov/11734212/" target="_blank" class="text-blue-600 underline hover:text-blue-800">Crystal structure of a cyclic form of bovine pancreatic trypsin inhibitor</a>, FEBS Lett. 509(1): 90-4.</li>
          <li>Wagner G, et al. 1976: <a href="https://pubmed.ncbi.nlm.nih.gov/9165/" target="_blank" class="text-blue-600 underline hover:text-blue-800">Dynamics of the aromatic amino acid residues in the globular conformation of the basic pancreatic trypsin inhibitor (BPTI). I. 1H NMR studies</a>, Biophys Struct Mech. 2(2): 139-58.</li>
          <li>Ilyina E, et al. 1997: <a href="https://pubmed.ncbi.nlm.nih.gov/9116018/" target="_blank" class="text-blue-600 underline hover:text-blue-800">A pulsed-field gradient NMR study of bovine pancreatic trypsin inhibitor self-association</a>, Biochemistry 36(11): 3383-8.</li>
          <li>Lu W, et al. 1998: <a href="https://pubmed.ncbi.nlm.nih.gov/9657378/" target="_blank" class="text-blue-600 underline hover:text-blue-800">Total chemical synthesis of bovine pancreatic trypsin inhibitor by native chemical ligation</a>, FEBS Lett. 429(1): 31-5.</li>
          <li>Ferrer M, et al. 1992: <a href="https://pubmed.ncbi.nlm.nih.gov/1282503/" target="_blank" class="text-blue-600 underline hover:text-blue-800">Solid-phase synthesis of bovine pancreatic trypsin inhibitor (BPTI) and two analogues: A chemical approach for evaluating the role of disulfide bridges in protein folding and stability</a>, Int J Pept Protein Res. 40(3-4): 194-207.</li>
          <li>Alexander J. 2020: <a href="https://onlinelibrary.wiley.com/doi/abs/10.1002/pep2.24166" target="_blank" class="text-blue-600 underline hover:text-blue-800">Total synthesis of bovine pancreatic trypsin inhibitor and the protein diastereomer [Gly37D-Ala]BPTI using Boc chemistry solid phase peptide synthesis</a>, Peptide Science 112(4).</li>
          <li>Bleackley MR, et al. 2014: <a href="https://pubmed.ncbi.nlm.nih.gov/24750237/" target="_blank" class="text-blue-600 underline hover:text-blue-800">Bovine pancreatic trypsin inhibitor is a new antifungal peptide that inhibits cellular magnesium uptake</a>, Mol Microbiol. 92(6): 1188-97.</li>
          <li>Ferreira GC, et al. 2023: <a href="https://pubmed.ncbi.nlm.nih.gov/36037882/" target="_blank" class="text-blue-600 underline hover:text-blue-800">Structural and functional properties of rBmTI-A: A Kunitz-BPTI serine protease inhibitor with therapeutical potential</a>, Biochimie 204: 1-7.</li>
          <li>Chang JY. 2011: <a href="https://pubmed.ncbi.nlm.nih.gov/20831444/" target="_blank" class="text-blue-600 underline hover:text-blue-800">Distinct folding pathways of two homologous disulfide proteins: bovine pancreatic trypsin inhibitor and tick anticoagulant peptide</a>, Antioxid Redox Signal 14(1): 127-35.</li>
          <li>Per√§kyl√§ M, Kollman PA. 2000: <a href="https://pubs.acs.org/doi/10.1021/ja991602p" target="_blank" class="text-blue-600 underline hover:text-blue-800">Why does trypsin cleave BPTI so slowly?</a>, J. Am. Chem. Soc. 122(14): 3436‚Äì44.</li>
          <li>Zakharova E, et al. 2008: <a href="https://pubmed.ncbi.nlm.nih.gov/18692070/" target="_blank" class="text-blue-600 underline hover:text-blue-800">Functional and structural roles of the Cys14-Cys38 disulfide of bovine pancreatic trypsin inhibitor</a>, J Mol Biol. 382(4): 998-1013.</li>
          <li>Czapinska H, et al. 2000: <a href="https://pubmed.ncbi.nlm.nih.gov/10653700/" target="_blank" class="text-blue-600 underline hover:text-blue-800">High-resolution structure of bovine pancreatic trypsin inhibitor with altered binding loop sequence</a>, J Mol Biol. 295(5): 1237-49.</li>
        </ol>
      </section>
      
      
  
  </main>
  
  

  <!-- start cta -->
  <section
  class="relative bg-blue-teal-gradient px-4 sm:px-8 lg:px-16 xl:px-40 2xl:px-64 py-12 text-center md:text-left">
  <div class="md:flex md:items-center md:justify-center">
    <h2 class="text-xl font-bold text-white">Jiagen Biotechnologies supplies quality aprotinin of various specifications. <br>Contact us at <a href="mailto:sales@jiagen.com">sales@jiagen.com</a> to place an order.</h2>

    <a href="../../order.html"
      class="px-8 py-4 bg-white text-blue-600 rounded inline-block font-semibold md:ml-8 mt-4 md:mt-0 
      hover:bg-teal-500 hover:text-white transition-colors duration-300">Order</a>
  </div>
</section>
<!-- end cta -->

<!-- start footer -->
<footer class="relative bg-[#ececec] text-gray-500 px-4 sm:px-8 lg:px-16 xl:px-40 2xl:px-64 py-12 lg:py-24">
  <div class="flex flex-col md:flex-row">
    <div class="w-full lg:w-auto lg:mx-4 lg:pr-8">
      <img src="../../assets/logo.svg" alt="Jiagen Biotechnologies" class="h-40 mb-2">

      <p class="text-gray-400">Empowering Discovery with Trusted Quality Materials.</p>

    </div>

    <div class="w-full lg:w-1/6 mt-8 lg:mt-0 lg:mx-4">
      <h5 class="uppercase tracking-wider font-semibold text-gray-500">Products</h5>
      <ul class="mt-4">
        <li class="mt-2"><a href="../proteins/proteins.html" title="" class="opacity-75 hover:opacity-100">Peptides/Proteins</a></li>
        <li class="mt-2"><a href="../enzymes/enzymes.html" title="" class="opacity-75 hover:opacity-100">Enzymes</a></li>
        <li class="mt-2"><a href="../coenzymes/coenzymes.html" title="" class="opacity-75 hover:opacity-100">Coenzymes</a></li>
        <li class="mt-2"><a href="../carbohydrates/carbohydrates.html" title="" class="opacity-75 hover:opacity-100">Carbohydrates</a></li>
        <li class="mt-2"><a href="../chemicals/chemicals.html" title="" class="opacity-75 hover:opacity-100">Chemicals</a></li>

      </ul>
    </div>

    <div class="w-full lg:w-2/6 mt-8 lg:mt-0 lg:mx-4 lg:pr-8">
      <h5 class="uppercase tracking-wider font-semibold text-gray-500">Contact Details</h5>
      <ul class="mt-4">
        <li>
          <a href="#" title="" class="block flex items-center opacity-75 hover:opacity-100">
            <span>
              <svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24"
                class="fill-current">
                <path
                  d="M12,2C7.589,2,4,5.589,4,9.995C3.971,16.44,11.696,21.784,12,22c0,0,8.029-5.56,8-12C20,5.589,16.411,2,12,2z M12,14 c-2.21,0-4-1.79-4-4s1.79-4,4-4s4,1.79,4,4S14.21,14,12,14z" />
              </svg>
            </span>
            <span class="ml-3">
              958 Mont√©e de Liesse, Saint-Laurent, QC, CAN
            </span>
          </a>
        </li>

        <li class="mt-4">
          <a href="#" title="" class="block flex items-center opacity-75 hover:opacity-100">
            <span>
              <svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24"
                class="fill-current">
                <path
                  d="M14.594,13.994l-1.66,1.66c-0.577-0.109-1.734-0.471-2.926-1.66c-1.193-1.193-1.553-2.354-1.661-2.926l1.661-1.66 l0.701-0.701L5.295,3.293L4.594,3.994l-1,1C3.42,5.168,3.316,5.398,3.303,5.643c-0.015,0.25-0.302,6.172,4.291,10.766 C11.6,20.414,16.618,20.707,18,20.707c0.202,0,0.326-0.006,0.358-0.008c0.245-0.014,0.476-0.117,0.649-0.291l1-1l0.697-0.697 l-5.414-5.414L14.594,13.994z" />
              </svg>
            </span>
            <span class="ml-3">
              +1 514-779-9623
            </span>
          </a>
        </li>
        <li class="mt-4">
          <a href="#" title="" class="block flex items-center opacity-75 hover:opacity-100">
            <span>
              <svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24"
                class="fill-current">
                <path
                  d="M20,4H4C2.896,4,2,4.896,2,6v12c0,1.104,0.896,2,2,2h16c1.104,0,2-0.896,2-2V6C22,4.896,21.104,4,20,4z M20,8.7l-8,5.334 L4,8.7V6.297l8,5.333l8-5.333V8.7z" />
              </svg>
            </span>
            <span class="ml-3">
              info@jiagen.com
            </span>
          </a>
        </li>
      </ul>
    </div>

    <div class="w-full lg:w-1/6 mt-8 lg:mt-0 lg:mx-4">
      

      <p class="text-sm text-gray-400 mt-12">¬© 2025 Jiagen Biotechnologies. <br class="hidden lg:block">All Rights Reserved.
      </p>
    </div>
  </div>
</footer>
<!-- end footer -->

</body>
</html>
